• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.

作者信息

Wang H C, Ho Y S

机构信息

Department of Pathology, Chang Gung Memorial Hospital Taipei, Taiwan, Republic of China.

出版信息

J Neurooncol. 1992 Jul;13(3):265-76. doi: 10.1007/BF00172480.

DOI:10.1007/BF00172480
PMID:1325543
Abstract

The grading systems of astrocytic tumors have long been the subject of controversy. A simple, objective and effective grading method is urgently needed for the evaluation of prognosis and the planning of treatment. This study investigated the relationship of clinical prognostic factors to the grading method of Daumas-Duport. This method determines the grade of tumor based on the presence or absence of four morphological criteria: nuclear atypia, mitosis, endothelial proliferation, and necrosis. A total of 143 astrocytic tumors were reviewed and screened, of which 65 ordinary and 13 pilocytic astrocytomas were selected for grading and comparison. Among ordinary astrocytomas, the grading method distinguished 9.2% grade 1, 26.2% grade 2, 36.9% grade 3, and 27.6% grade 4. At least 2-year follow-up was available on all surviving patients. Median survival was 57, 32, 12.5, and 8 months in grades 1, 2, 3, and 4 tumors, respectively. By a multiple regression model and analysis of variance, grade is significantly associated with survival (total regression coefficient r = 0.711). Age lost its significance on survival after multiple regression analysis. Sex, location, and surgical procedure were all unrelated to survival after regression. The age distribution and survival of patients with pilocytic astrocytomas revealed that this is a distinct disease entity and should not be admixed with ordinary astrocytomas in a grading scheme.

摘要

相似文献

1
Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system.
J Neurooncol. 1992 Jul;13(3):265-76. doi: 10.1007/BF00172480.
2
Grading of astrocytomas. A simple and reproducible method.星形细胞瘤的分级。一种简单且可重复的方法。
Cancer. 1988 Nov 15;62(10):2152-65. doi: 10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t.
3
Correlates of survival and the Daumas-Duport grading system for astrocytomas.星形细胞瘤的生存相关因素及Daumas-Duport分级系统
J Neurosurg. 1991 Jan;74(1):27-37. doi: 10.3171/jns.1991.74.1.0027.
4
Cellular proliferation in pilocytic and diffuse astrocytomas.毛细胞型和弥漫性星形细胞瘤中的细胞增殖
J Neuropathol Exp Neurol. 1999 Jan;58(1):46-53. doi: 10.1097/00005072-199901000-00006.
5
[Malignancy grading of glial tumors. I. Astrocytomas].[神经胶质瘤的恶性分级。I. 星形细胞瘤]
Zentralbl Allg Pathol. 1985;130(6):451-62.
6
Grading astrocytomas.星形细胞瘤分级
Neurosurg Clin N Am. 1994 Jan;5(1):35-41.
7
[Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].[根据新的组织病理学分级对星形细胞瘤增殖指数进行的免疫组织化学研究]
Rinsho Byori. 1995 May;43(5):483-6.
8
Supratentorial pilocytic astrocytomas. A clinicopathologic, prognostic, and flow cytometric study of 51 patients.幕上毛细胞型星形细胞瘤。51例患者的临床病理、预后及流式细胞术研究
Cancer. 1993 Aug 15;72(4):1335-42. doi: 10.1002/1097-0142(19930815)72:4<1335::aid-cncr2820720431>3.0.co;2-e.
9
Prognostic role of urokinase-type plasminogen activator in human gliomas.尿激酶型纤溶酶原激活剂在人类胶质瘤中的预后作用。
Am J Pathol. 1995 Jul;147(1):114-23.
10
Histological grading and bromodeoxyuridine labeling index of astrocytomas. Comparative study in a series of 60 cases.
J Neurosurg. 1991 Aug;75(2):202-5. doi: 10.3171/jns.1991.75.2.0202.

引用本文的文献

1
ASTROCYTOMAS AND PROGNOSIS-FROM MORPHOLOGY TO TUMOR BIOLOGY.星形细胞瘤与预后——从形态学到肿瘤生物学
Med J Armed Forces India. 2000 Apr;56(2):103-109. doi: 10.1016/S0377-1237(17)30122-3. Epub 2017 Jun 10.
2
Combination chemotherapy with carmustine and cisplatin before, during, and after radiotherapy for adult malignant gliomas.对于成人恶性胶质瘤,在放疗前、放疗期间及放疗后采用卡莫司汀和顺铂联合化疗。
J Neurooncol. 1995;25(3):215-20. doi: 10.1007/BF01053154.

本文引用的文献

1
A simplified classification of the gliomas.胶质瘤的简化分类。
Proc Staff Meet Mayo Clin. 1949 Feb 2;24(3):71-5.
2
Grading of gliomas.胶质瘤的分级
Acta Pathol Microbiol Scand. 1950;27(1):51-64.
3
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.术后放疗与亚硝基脲类药物治疗恶性胶质瘤的随机对照比较。
N Engl J Med. 1980 Dec 4;303(23):1323-9. doi: 10.1056/NEJM198012043032303.
4
Treatment of neuroectodermal brain tumors.神经外胚层脑肿瘤的治疗。
Ann Neurol. 1982 Sep;12(3):231-7. doi: 10.1002/ana.410120302.
5
A commentary on the biology and growth kinetics of low-grade and high-grade gliomas.
J Neurosurg. 1984 Nov;61(5):895-900. doi: 10.3171/jns.1984.61.5.0895.
6
Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres.大脑半球低级别星形细胞瘤的神经外科治疗
J Neurosurg. 1984 Oct;61(4):665-73. doi: 10.3171/jns.1984.61.4.0665.
7
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas.坏死作为幕上恶性星形细胞瘤的预后标准。
Cancer. 1983 Aug 1;52(3):550-4. doi: 10.1002/1097-0142(19830801)52:3<550::aid-cncr2820520327>3.0.co;2-c.
8
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.抗生物素蛋白-生物素-过氧化物酶复合物(ABC)在免疫过氧化物酶技术中的应用:ABC法与未标记抗体(PAP)法的比较。
J Histochem Cytochem. 1981 Apr;29(4):577-80. doi: 10.1177/29.4.6166661.
9
The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4.
J Neurosurg. 1973 Apr;38(4):448-52. doi: 10.3171/jns.1973.38.4.0448.
10
Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.具有非典型或间变性特征的星形细胞瘤患者的生存情况和预后
J Neurooncol. 1985;3(2):99-103. doi: 10.1007/BF02228884.